Skip to menu Skip to content Skip to footer

Proof-of-concept study of mRNA-based gene therapy for Mitochondrial Neuro-Gastro-lntestinal Encephalomyopathy (The Lily Foundation Research Grant administered by the University of Cambridge) (2024-2025)

Experts

Associate Professor Seth Cheetham

Affiliate of ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR)
ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals
Australian Institute for Bioengineering and Nanotechnology
Director, National Biologics Facility and AIBN Group Leader
Australian Institute for Bioengineering and Nanotechnology
Seth Cheetham
Seth Cheetham